RxDoctor Payments DataLook up a doctor →

Daniel Lorch

Pulmonary Disease · Brandon, FLNPI 1821033242

Payments from drug & device makers

$5,455,833in general payments, 2019–2025

Across 677 payments — averaging $8058.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2.8M
  • Modernatx, Inc.$530K
  • Alkermes, Inc.$467K
  • Eisai Inc.$440K
  • Merck$312K
  • Jazz Pharmaceuticals Inc.$248K
  • plus $633K from 19 others
$152,403in research payments, 2019–2025

Across 16 payments — averaging $9525.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$151K
  • Lexicon Pharmaceuticals, Inc.$1K

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,455,833 in reported general payments places this provider in the 95th percentile of 953 pulmonary disease providers in Florida.

See all pulmonary disease providers in Florida

Other pulmonary disease in Brandon

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →